Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease

Kenneth Ilett, W.M. Castleden, Y. Vandongen, M.C. Stacey, M.A. Butler, F.F. Kadlubar

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	317-322
Journal	Clinical Pharmacology and Therapeutics
Volume	54
Publication status	Published - 1993

Cite this

@article{ff377c5d3b254920a61263d516cee613,

title = "Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease",

author = "Kenneth Ilett and W.M. Castleden and Y. Vandongen and M.C. Stacey and M.A. Butler and F.F. Kadlubar",

year = "1993",

language = "English",

volume = "54",

pages = "317--322",

journal = "Clinical pharmacology & therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease

AU - Ilett, Kenneth

AU - Castleden, W.M.

AU - Vandongen, Y.

AU - Stacey, M.C.

AU - Butler, M.A.

AU - Kadlubar, F.F.

PY - 1993

Y1 - 1993

M3 - Article

VL - 54

SP - 317

EP - 322

JO - Clinical pharmacology & therapeutics

JF - Clinical pharmacology & therapeutics

SN - 0009-9236

ER -